Department of Surgery, NYU Langone Medical Center, New York, USA.
World J Surg Oncol. 2009 Dec 8;7:94. doi: 10.1186/1477-7819-7-94.
MLH1 is one of six known genes responsible for DNA mismatch repair (MMR), whose inactivation leads to HNPCC. It is important to develop genotype-phenotype correlations for HNPCC, as is being done for other hereditary cancer syndromes, in order to guide surveillance and treatment strategies in the future.
We report a 47 year-old male with hereditary nonpolyposis colorectal cancer (HNPCC) associated with a novel germline mutation in MLH1. This patient expressed a rare and severe phenotype characterized by three synchronous primary carcinomas: ascending and splenic flexure colon adenocarcinomas, and ureteral carcinoma. Ureteral neoplasms in HNPCC are most often associated with mutations in MSH2 and rarely with mutations in MLH1. The reported mutation is a two base pair insertion into exon 10 (c.866_867insCA), which results in a premature stop codon.
Our case demonstrates that HNPCC patients with MLH1 mutations are also at risk for ureteral neoplasms, and therefore urological surveillance is essential. This case adds to the growing list of disease-causing MMR mutations, and contributes to the development of genotype-phenotype correlations essential for assessing individual cancer risk and tailoring of optimal surveillance strategies. Additionally, our case draws attention to limitations of the Amsterdam Criteria and the need to maintain a high index of suspicion when newly diagnosed colorectal cancer meets the Bethesda Criteria. Establishment of the diagnosis is the crucial first step in initiating appropriate surveillance for colorectal cancer and other HNPCC-associated tumors in at-risk individuals.
MLH1 是负责 DNA 错配修复 (MMR) 的六个已知基因之一,其失活导致 HNPCC。与其他遗传性癌症综合征一样,开发 HNPCC 的基因型-表型相关性非常重要,以便为未来的监测和治疗策略提供指导。
我们报告了一名 47 岁男性,患有遗传性非息肉病性结直肠癌 (HNPCC),与 MLH1 中的新种系突变相关。该患者表现出罕见且严重的表型,特征为三个同步原发性癌:升结肠和脾曲结肠癌,以及输尿管癌。HNPCC 中的输尿管肿瘤最常与 MSH2 突变相关,很少与 MLH1 突变相关。报道的突变是外显子 10 中的两个碱基插入 (c.866_867insCA),导致提前出现终止密码子。
我们的病例表明,MLH1 突变的 HNPCC 患者也有发生输尿管肿瘤的风险,因此需要进行泌尿科监测。该病例增加了越来越多的致病变异 MMR 突变,并为评估个体癌症风险和制定最佳监测策略的基因型-表型相关性的发展做出了贡献。此外,我们的病例引起了对阿姆斯特丹标准的局限性以及在新诊断的结直肠癌符合贝塞斯达标准时保持高度怀疑的必要性的关注。建立诊断是启动高危个体结直肠癌和其他 HNPCC 相关肿瘤适当监测的关键第一步。